Jun 25, 2021Vividion Therapeutics Files for IPOVividion Therapeutics Inc., a biotechnology company that seeks to develop drugs for cancer and immune disorders using "traditionally...
Jun 22, 2021Tempest and Millendo Announce Stockholder Approval of MergerTempest to Trade on Nasdaq Public Markets Under Ticker “TPST” SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE...
Jun 17, 2021Lyell Immunopharma Announces Pricing of Initial Public OfferingSOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming...
Jun 2, 2021MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61%Shares of MorphoSys AG ADR MOR, -12.90% were down 8.9% in premarket trading on Wednesday after the company announced a $1.7 billion...